Given the potential connection between, and the coexistence of, lung fibrosis and AHR in chronic asthma [24], we explored the possibility that administration of L-NIL, a clinically tested iNOS inhibitor, may be protective against AHR upon both acute and chronic exposures to OVA in mice. This evidence concerns the gene NOS2 and pulmonary fibrosis.